Template:Valganciclovir hydrochloride: Difference between revisions

Revision as of 14:28, 30 December 2013

valganciclovir hydrochloride
VALCYTE^® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
Patient Counseling Information
How Supplied
Labels and Packages

@@ Line 23: / Line 23: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[valganciclovir hydrochloride dosage and administration|Dosage and Administration]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[valganciclovir hydrochloride patient counseling information|Patient Counseling Information]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[valganciclovir hydrochloride how supplied|How Supplied]]